Showing results (971-980 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|February 10, 2016
Risk factors associated with postoperative pain after ophthalmic surgery: a prospective studyMladen Lesin, Mirna Dzaja Lozo, Zeljka Duplancic-Sundov, et al.Therapeutics and Clinical Risk Management|March 30, 2016
Comparison of propofol-hydromorphone and propofol-dexmedetomidine in patients with intubation after maxillofacial plastic surgeryWei Peng, Tiejun Zhang, Yanlin WangTherapeutics and Clinical Risk Management|March 30, 2016
Concentrated insulins: the new basal insulinsElizabeth M Lamos, Lisa M Younk, Stephen N DavisTherapeutics and Clinical Risk Management|April 5, 2016
TotalTrack video intubating laryngeal mask in super-obese patients - series of casesTomasz GaszynskiTherapeutics and Clinical Risk Management|April 5, 2016
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerationsLuca Prosperini, Simona PontecorvoTherapeutics and Clinical Risk Management|August 10, 2017
Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysisJan Sperl, Sona Frankova, Miluse Kreidlova, et al.Therapeutics and Clinical Risk Management|August 11, 2017
Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery diseaseAnita Jukic, Dorotea Bozic, Dusko Kardum, et al.Therapeutics and Clinical Risk Management|July 26, 2017
Diagnostic reliability of pediatric appendicitis score, ultrasound and low-dose computed tomography scan in children with suspected acute appendicitisAshraf Othman Sayed, Nancy Selim Zeidan, Dalia Monir Fahmy, et al.Therapeutics and Clinical Risk Management|August 18, 2017
Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis painXiushuai Shang, Zhaofei Wang, Hairong TaoTherapeutics and Clinical Risk Management|August 24, 2017
Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practiceKathleen A Fairman, Lindsay E Davis, David A SclarPageof 256